Home LiteratureArticle Details
PMID: 8770904 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Structural features of thyroid hormone response elements that increase susceptibility to inhibition by an RTH mutant thyroid hormone receptor.

Endocrinology ·Vol. 137 ·No. 7 ·1996-07-00 ·Pages 2833-41

Zavacki AM, Harney JW, Brent GA, Larsen PR

Abstract

The chicken lysozyme silencer F2 (F2) thyroid hormone response element (TRE) contains an unusual everted palindromic arrangement, has a high affinity for thyroid hormone receptor (TR) homodimers, and is especially sensitive to dominant negative inhibition by, the T3 resistance (RTH) mutant TR beta P453H. We used various TREs and TR mutations to determine the mechanisms for this sensitivity. Changing the F2 orientation from an everted palindrome to a direct repeat with a 4-bp gap (DR+4) (F2-DR) decreased the sensitivity to inhibition at high T3 concentrations, while a loss of this sensitivity occurred with a palindromic arrangement of these same half-sites. F2 contains the dinucleotide TG 5' to each consensus half-site conforming to the optimal TR-binding octamer, YRRGGTCA. A T to A change in position 1 of both F2 half-sites markedly reduced T3-induction, yet only slightly reduced TR homodimer or TR-retinoid X receptor (RXR) heterodimer binding. The TR beta ninth heptad mutation, L428R, prevents TR heterodimerization with RXR and eliminates the inhibitory effect of the P453H mutant TR on the F2-DR, but not the F2 element. Structural features of a TRE that favor strong TR binding of both TR homodimers and TR-RXR heterodimers containing the mutant TR, such as the everted palindromic conformation or the optimal TR-binding consensus octamer, enhance the sensitivity of a TRE to inhibition by the mutant TR. Thus, both half-site orientation and sequence contribute to the sensitivity of a given TRE to dominant negative inhibition by a mutant TR.

MeSH Terms
Amino Acid Sequence Animals Base Sequence Binding Sites Cell Line Chickens Chloramphenicol O-Acetyltransferase/biosynthesis Consensus Sequence Drug Resistance Gene Rearrangement Growth Hormone/biosynthesis Humans Macromolecular Substances Molecular Sequence Data Mutagenesis, Site-Directed Point Mutation Rats Receptors, Thyroid Hormone/antagonists & inhibitors,biosynthesis Recombinant Proteins/antagonists & inhibitors,biosynthesis Regulatory Sequences, Nucleic Acid Repetitive Sequences, Nucleic Acid Transfection Triiodothyronine/pharmacology
Chemicals
Macromolecular Substances Receptors, Thyroid Hormone Recombinant Proteins Triiodothyronine Growth Hormone Chloramphenicol O-Acetyltransferase
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Zavacki A M
Program in Biological and Biomedical Sciences, Thyroid Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
Harney J W
Brent G A
Larsen P R
Article Info
Journal
Endocrinology
Abbr.
Endocrinology
ISSN
0013-7227
Published
1996-07-00
Pages
2833-41
Language
English
Region
United States
NLM ID
0375040
Subset
IM
Grants
NIDDK NIH HHS · R01-DK-44128 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com